Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376223844> ?p ?o ?g. }
- W4376223844 endingPage "370" @default.
- W4376223844 startingPage "353" @default.
- W4376223844 abstract "Abstract Cardiovascular diseases (CVD) remain the leading cause of death worldwide, and pharmacotherapy of most of them is suboptimal. Thus, there is a clear unmet clinical need to develop new pharmacological strategies with greater efficacy and better safety profiles. In this review, we summarize the most relevant advances in cardiovascular pharmacology in 2022, including the approval of first-in-class drugs that open new avenues for the treatment of obstructive hypertrophic cardiomyopathy (mavacamten), type 2 diabetes mellitus (tirzepatide), and heart failure (HF) independent of left ventricular ejection fraction (sodium-glucose cotransporter 2 inhibitors). We also dealt with fixed dose combination therapies repurposing different formulations of ‘old’ drugs with well-known efficacy and safety for the treatment of patients with acute decompensated HF (acetazolamide plus loop diuretics), atherosclerotic cardiovascular disease (moderate-dose statin plus ezetimibe), Marfan syndrome (angiotensin receptor blockers plus β-blockers), and secondary cardiovascular prevention (i.e. low-dose aspirin, ramipril, and atorvastatin), thereby filling existing gaps in knowledge and opening new avenues for the treatment of CVD. Clinical trials confirming the role of dapagliflozin in patients with HF and mildly reduced or preserved ejection fraction, long-term evolocumab to reduce the risk of cardiovascular events, vitamin K antagonists for stroke prevention in patients with rheumatic heart disease-associated atrial fibrillation, antibiotic prophylaxis in patients at high risk for infective endocarditis before invasive dental procedures, and vutrisiran for the treatment of hereditary transthyretin-related amyloidosis with polyneuropathy were also reviewed. Finally, we briefly discuss recent clinical trials suggesting that FXIa inhibitors may have the potential to uncouple thrombosis from haemostasis and attenuate/prevent thromboembolic events with minimal disruption of haemostasis." @default.
- W4376223844 created "2023-05-13" @default.
- W4376223844 creator A5001951606 @default.
- W4376223844 creator A5002326750 @default.
- W4376223844 creator A5013553039 @default.
- W4376223844 creator A5020872201 @default.
- W4376223844 creator A5026696245 @default.
- W4376223844 creator A5027161261 @default.
- W4376223844 creator A5028979797 @default.
- W4376223844 creator A5047759340 @default.
- W4376223844 creator A5056767810 @default.
- W4376223844 creator A5057207523 @default.
- W4376223844 creator A5065814828 @default.
- W4376223844 creator A5066283101 @default.
- W4376223844 creator A5074039900 @default.
- W4376223844 creator A5079199431 @default.
- W4376223844 creator A5080502826 @default.
- W4376223844 date "2023-05-11" @default.
- W4376223844 modified "2023-10-15" @default.
- W4376223844 title "New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022" @default.
- W4376223844 cites W1739754559 @default.
- W4376223844 cites W1920355337 @default.
- W4376223844 cites W1967861071 @default.
- W4376223844 cites W1988181694 @default.
- W4376223844 cites W2018120331 @default.
- W4376223844 cites W2042639209 @default.
- W4376223844 cites W2084800598 @default.
- W4376223844 cites W2088038696 @default.
- W4376223844 cites W2108819018 @default.
- W4376223844 cites W2113523560 @default.
- W4376223844 cites W2134617609 @default.
- W4376223844 cites W2139359396 @default.
- W4376223844 cites W2163207768 @default.
- W4376223844 cites W2164089346 @default.
- W4376223844 cites W2225967663 @default.
- W4376223844 cites W2277697424 @default.
- W4376223844 cites W2338854794 @default.
- W4376223844 cites W2345738618 @default.
- W4376223844 cites W2462494713 @default.
- W4376223844 cites W2513422586 @default.
- W4376223844 cites W2561678715 @default.
- W4376223844 cites W2570787279 @default.
- W4376223844 cites W2734641374 @default.
- W4376223844 cites W2747734729 @default.
- W4376223844 cites W2756203218 @default.
- W4376223844 cites W2758328078 @default.
- W4376223844 cites W2772356304 @default.
- W4376223844 cites W2791931685 @default.
- W4376223844 cites W2798111298 @default.
- W4376223844 cites W2884965675 @default.
- W4376223844 cites W2895135221 @default.
- W4376223844 cites W2900034165 @default.
- W4376223844 cites W2909765747 @default.
- W4376223844 cites W2911333943 @default.
- W4376223844 cites W2944409590 @default.
- W4376223844 cites W2944922806 @default.
- W4376223844 cites W2952789707 @default.
- W4376223844 cites W2953804067 @default.
- W4376223844 cites W2996947593 @default.
- W4376223844 cites W3006057482 @default.
- W4376223844 cites W3006849990 @default.
- W4376223844 cites W3015345942 @default.
- W4376223844 cites W3021070076 @default.
- W4376223844 cites W3082188176 @default.
- W4376223844 cites W3101533148 @default.
- W4376223844 cites W3104775553 @default.
- W4376223844 cites W3183842190 @default.
- W4376223844 cites W3183857127 @default.
- W4376223844 cites W3189369858 @default.
- W4376223844 cites W3193297191 @default.
- W4376223844 cites W3193598686 @default.
- W4376223844 cites W3196464088 @default.
- W4376223844 cites W3209664507 @default.
- W4376223844 cites W4200586754 @default.
- W4376223844 cites W4210521381 @default.
- W4376223844 cites W4213427170 @default.
- W4376223844 cites W4220837239 @default.
- W4376223844 cites W4221136197 @default.
- W4376223844 cites W4224295659 @default.
- W4376223844 cites W4249001882 @default.
- W4376223844 cites W4280635779 @default.
- W4376223844 cites W4283804747 @default.
- W4376223844 cites W4284884112 @default.
- W4376223844 cites W4285810094 @default.
- W4376223844 cites W4286715944 @default.
- W4376223844 cites W4292342674 @default.
- W4376223844 cites W4292702960 @default.
- W4376223844 cites W4293176633 @default.
- W4376223844 cites W4293354639 @default.
- W4376223844 cites W4293410833 @default.
- W4376223844 cites W4293426420 @default.
- W4376223844 cites W4293797820 @default.
- W4376223844 cites W4293872386 @default.
- W4376223844 cites W4294069033 @default.
- W4376223844 cites W4294613044 @default.
- W4376223844 cites W4297179199 @default.
- W4376223844 cites W4300689929 @default.
- W4376223844 cites W4306871090 @default.